Dela Cruz, Jenivy B.
HRN: 24-10-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2023
CEFUROXIME 1.5GM (VIAL)
11/13/2023
11/20/2023
IV
250mg
Q8
T/c Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes